Lilly Trained Sales Force to Ignore Drug's Risks - Bloomberg
DOW JONES NEWSWIRES Sales representatives pushed the drug, linked to weight gain and diabetes, to
primary-care and nursing-home doctors while ignoring its risks, Bloomberg News
said, citing documents filed in a lawsuit by The drugs also were recommended for patients who weren't diagnosed with
schizophrenia or bipolar disorder, Bloomberg News reported, citing complaints
filed by Lilly doesn't engage in improper marketing and hasn't downplayed the risks,
spokeswoman Full story at http://www.bloomberg.com/apps/news?pid=20601109&sid= a3zg322ZNbDw&refer=home Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http:// www.djnewsplus.com/al?rnd=%2B%2B0A4EKn7ZlAi6szOQUadw%3D%3D. You can use this link on the day this article is published and the following day. (END) Dow Jones Newswires |
|